GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Suzhou Basecare Medical Corp 2170.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

1.33

+1.53%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Suzhou Basecare Medical Corp

Its shares trade on HKEX under the ticker 2170.HK. It has been listed since 8 February 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥233.3m and a net loss of CN¥223.5m. At that date it held total assets of CN¥1.45bn and shareholders' equity of CN¥935.1m.

Suzhou Basecare Medical Corp. Ltd. is an investment holding company, which engages in the provision of genetic testing solution for assisted reproduction. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2021-02-08. The firm provides genetic testing solutions and sells genetic testing equipment and instruments. The genetic testing solutions include sales of testing kits and provision of testing services. The firm's main products include PGT-A kits. The firm mainly conducts business within the domestic market.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
8 Feb 2021
Employees
488
Website
basecare.cn ↗

Leadership

Pay as last reported

  • Mr. Bo LiangExecutive Chairman of the Board, General Manager, since 2010CN¥3.0m
  • Mr. Lejun YinChief Financial Officer, Joint Company Secretary
  • Mr. Maoshe RuiChief Operating Officer, since 2017CN¥306,000
  • Mr. Lingyin KongChief Technical Officer, Executive Director, since 2014CN¥886,000
  • Ms. Junchao JiangExecutive Director, since 2024
  • Mr. Ming Fai ChungJoint Company Secretary
  • Mr. Yang LingNon-Executive Director
  • Mr. Weipeng WangNon-Executive Director
  • Mr. Wenbo XuNon-Executive Director
  • Dr. Xixiong KangIndependent Non-Executive DirectorCN¥172,000
  • Mr. Siu Wing LamIndependent Non-Executive Director
  • Mr. Shu Biu YeungNon-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Provides genetic testing solutions for assisted reproduction
  • Offers genetic testing equipment and instruments for sale
  • Mainly operates within the domestic market

Weaknesses

  • Limited to domestic market operations
  • Relies on PGT-A kits as main product
  • No international market presence

Opportunities

  • Expansion into international markets
  • Growth in genetic testing demand domestically
  • Potential for new product development

Threats

  • Dependence on domestic market for revenue
  • Competition in genetic testing industry
  • Regulatory changes affecting healthcare sector

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.